Korro Bio, Inc.
KRRO
$20.26
$0.190.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.10% | -7.75% | -2.97% | -22.33% | -24.23% |
| Total Depreciation and Amortization | 36.38% | 14.58% | -1.79% | -2.92% | 5.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.10% | -20.04% | 6.28% | 89.84% | 155.85% |
| Change in Net Operating Assets | 189.56% | 1,851.38% | 217.32% | 1.64% | 453.86% |
| Cash from Operations | 3.02% | 9.86% | 10.71% | -20.38% | -8.89% |
| Capital Expenditure | 51.09% | -3.99% | -128.46% | -138.47% | -49.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.34% | -3,727.25% | -654.97% | -543.11% | -404.07% |
| Cash from Investing | 105.64% | -755.19% | -1,204.86% | -868.40% | -586.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.17% | -55.13% | -55.13% | 61,229.48% | 142,280.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -265.03% | -5,219.91% |
| Cash from Financing | -99.13% | -51.31% | -63.06% | 393.23% | 362.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -286.37% | -223.98% | -186.65% | 908.33% | 683.82% |